Literature DB >> 3511652

Cellular mechanism of action of loop diuretics: implications for drug effectiveness and adverse effects.

P U Feig.   

Abstract

The loop diuretics inhibit a transport system that moves sodium, potassium and chloride across cell membranes of many tissues, including the thick ascending loop of Henle. This inhibitory effect is responsible for their natriuretic effect. Of the agents available for clinical use, bumetanide is the most powerful; it has an in vitro transport inhibitory potency and an in vivo natriuretic effectiveness that is approximately 50-fold that of furosemide. This increased potency and the consequent decreased dose requirement give bumetanide the potential for increased effectiveness and decreased incidence of adverse effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511652     DOI: 10.1016/0002-9149(86)91001-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Cicoira Maria Antonietta; Emiliano Calvi; Andrea Faggiano; Caterina Maffeis; Marco Bosisio; Marco De Stefano; Stefano Carugo; Pompilio Faggiano
Journal:  Curr Heart Fail Rep       Date:  2022-01-17

3.  Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide.

Authors:  Yongxiang Zhao; Kasturi Roy; Pietro Vidossich; Laura Cancedda; Marco De Vivo; Biff Forbush; Erhu Cao
Journal:  Nat Commun       Date:  2022-05-18       Impact factor: 17.694

4.  Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4.

Authors:  A A K El-Sheikh; J J M W van den Heuvel; J B Koenderink; F G M Russel
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.